Advanced search
Publication Cover
Patient Preference and Adherence Volume 8, 2014 - Issue
Submit an article Journal homepage
69
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Patient perspectives on switching disease-modifying therapies in the NARCOMS registry

Amber R Salter1 Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USACorrespondence[email protected]
,
Ruth Ann Marrie2 Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada;3 Department of Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada
,
Neetu Agashivala4 Novartis Pharmaceutical Corporation, East Hanover, NJ, USA
,
Daniel A Belletti4 Novartis Pharmaceutical Corporation, East Hanover, NJ, USA
,
Edward Kim4 Novartis Pharmaceutical Corporation, East Hanover, NJ, USA
,
Gary R Cutter1 Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USA
,
Stacey S Cofield1 Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USA
&
Tuula Tyry5 Division of Neurology, St. Joseph’s Hospital and Medical Center, Phoenix, AZ, USA
 show all
Pages 971-979 | Published online: 04 Jul 2014

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Melissa A. Frasco, Tiffany Shih, Devin Incerti, Oliver Diaz Espinosa, Diana K. Vania & Nina Thomas. (2017) Incremental net monetary benefit of ocrelizumab relative to subcutaneous interferon β-1a . Journal of Medical Economics 20:10, pages 1074-1082.
Read now

Articles from other publishers (12)

Charee M. Thompson, Manuel D. Pulido, Sara Babu, Nicole Zenzola & Chungyi Chiu. (2022) Communication between persons with multiple sclerosis and their health care providers: A scoping review. Patient Education and Counseling 105:12, pages 3341-3368.
Crossref
A. Manzano, I. Eskyté, H.L. Ford, S.H. Pavitt, B. Potrata, K. Schmierer, J. Chataway, E.J.D. Webb, D. Meads, G. Pepper & H.L. Bekker. (2020) Patient perspective on decisions to switch disease-modifying treatments in relapsing-remitting multiple sclerosis. Multiple Sclerosis and Related Disorders 46, pages 102507.
Crossref
James Bowen, Rina Mehta, Corey Pelletier, Marc Tian, Virginia Noxon, Barbara H. Johnson & Machaon Bonafede. (2020) Treatment Patterns Among Patients with Multiple Sclerosis Initiating Second-Line Disease-Modifying Therapy. Advances in Therapy 37:7, pages 3163-3177.
Crossref
Peter Joseph Jongen. (2019) Observational designs in clinical multiple sclerosis research: Particulars, practices and potentialities. Multiple Sclerosis and Related Disorders 35, pages 142-149.
Crossref
Mathias Mäurer, Klaus Tiel-Wilck, Eckard Oehm, Nils Richter, Michael Springer, Patrick Oschmann, Arndt Manzel, Stefanie Hieke-Schulz, Vera Zingler, Julia A. Kandenwein, Tjalf Ziemssen & Ralf A. Linker. (2019) Reasons to switch: a noninterventional study evaluating immunotherapy switches in a large German multicentre cohort of patients with relapsing-remitting multiple sclerosis. Therapeutic Advances in Neurological Disorders 12, pages 175628641989207.
Crossref
Ieva Eskyte, Ana Manzano, George Pepper, Sue Pavitt, Helen Ford, Hilary Bekker, Jeremy Chataway, Klaus Schmierer, David Meads, Edward Webb & Barbara Potrata. (2019) Understanding treatment decisions from the perspective of people with relapsing remitting multiple Sclerosis: A critical interpretive synthesis. Multiple Sclerosis and Related Disorders 27, pages 370-377.
Crossref
Patricia K. Coyle, Bhupendra Khatri, Keith R. Edwards, José E. Meca-Lallana, Steve Cavalier, Pascal Rufi, Myriam Benamor, Karthinathan Thangavelu, Miqun Robinson & Ralf Gold. (2018) Patient-reported outcomes in patients with relapsing forms of MS switching to teriflunomide from other disease-modifying therapies: Results from the global Phase 4 Teri-PRO study in routine clinical practice. Multiple Sclerosis and Related Disorders 26, pages 211-218.
Crossref
Victoria F. Wagner, Hope Northrup, S. Shahrukh Hashmi, Joanne M. Nguyen, Mary Kay Koenig & Jessica M. Davis. (2017) Attitudes of Individuals with Gaucher Disease toward Substrate Reduction Therapies. Journal of Genetic Counseling 27:1, pages 169-176.
Crossref
Bianca Weinstock-Guttman, Jennie Medin, Nasreen Khan, Jonathan R. Korn, Ellen Lathi, Jason Silversteen, Jonathan Calkwood, Diego Silva & Robert Zivadinov. (2017) Assessing ‘No Evidence of Disease Activity’ Status in Patients with Relapsing-Remitting Multiple Sclerosis Receiving Fingolimod in Routine Clinical Practice: A Retrospective Analysis of the Multiple Sclerosis Clinical and Magnetic Resonance Imaging Outcomes in the USA (MS-MRIUS) Study. CNS Drugs 32:1, pages 75-84.
Crossref
S. Michelle Driedger, Ryan Maier, Ruth Ann Marrie & Melissa Brouwers. (2017) Caught in a no-win situation: discussions about CCSVI between persons with multiple sclerosis and their neurologists – a qualitative study. BMC Neurology 17:1.
Crossref
Stacey S. Cofield, Nina Thomas, Tuula Tyry, Robert J. Fox & Amber Salter. (2017) Shared Decision Making and Autonomy Among US Participants with Multiple Sclerosis in the NARCOMS Registry. International Journal of MS Care 19:6, pages 303-312.
Crossref
Darwin Vizcarra-Escobar, Andrea Mendiola-Yamasato, Victor Anculle-Arauco, Joaquin Vizcarra-Pasapera & Daniel Guillen-Mendoza. (2015) Treatment Issues in Multiple Sclerosis in Latin America. Neuroepidemiology 44:1, pages 66-68.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.